ATF4 and Parkinson disease: While we did not find any Atf4 footprint distribution abnormality in the G2019S LRRK2 transgenic brain, we cannot exclude the possibility that increased ribosomal processivity could impair the ISR, thereby incurring a long-term cellular stress in G2019S LRRK2 PD.